Latham & Watkins has advised Praxis Precision Medicines, Inc., and Mintz, Levin, Cohn, Ferris, Glovsky, and Popeo has advised the underwriters. Praxis Precision Medicines, Inc. (Nasdaq:...
Praxis Precision Medicines Completes $603 Million Public Offering
Praxis Precision Medicines’ $264 Milion Collaboration and License Agreement with Tenacia Biotechnology
Sidley Austin represented Praxis Precision Medicines, Inc. in the transaction, and Ropes & Gray advised Tenacia. Praxis Precision Medicines, Inc. (NASDAQ: PRAX) announced it has entered...


























